Maria Leandro: Difference between revisions
From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
Notjusttired (talk | contribs) m (Text replacement - "last4=" to "last4 = ") |
Notjusttired (talk | contribs) m (Text replacement - "last=" to "last = ") |
||
| Line 1: | Line 1: | ||
{{stub}} | {{stub}} | ||
{{NeedsImage}} | {{NeedsImage}} | ||
'''Maria Leandro''', MD, PhD, is a Consultant Rheumatologist and a researcher at the Division of Medicine, Centre of Rheumatology Research, University College London, London, [[United Kingdom]]. Her research interests are in inflammatory arthritis, rheumatoid arthritis, [[B cell]] directed therapies in autoimmune diseases and role of B cells in the pathogenesis of autoimmune diseases.<ref>{{Cite web|url=https://www.uclh.nhs.uk/OurServices/Consultants/Pages/DrMariaLeandro.aspx|title=Dr Maria Leandro - UCL Hospitals|last=|first = |date=|website=|archive-url=|archive-date=|url-status=|access-date=}}</ref> | '''Maria Leandro''', MD, PhD, is a Consultant Rheumatologist and a researcher at the Division of Medicine, Centre of Rheumatology Research, University College London, London, [[United Kingdom]]. Her research interests are in inflammatory arthritis, rheumatoid arthritis, [[B cell]] directed therapies in autoimmune diseases and role of B cells in the pathogenesis of autoimmune diseases.<ref>{{Cite web|url=https://www.uclh.nhs.uk/OurServices/Consultants/Pages/DrMariaLeandro.aspx|title=Dr Maria Leandro - UCL Hospitals|last = |first = |date=|website=|archive-url=|archive-date=|url-status=|access-date=}}</ref> | ||
== Notable studies == | == Notable studies == | ||
*2016, Extended [[B cell]] phenotype in patients with [[ME/CFS|Myalgic Encephalomyelitis/Chronic Fatigue Syndrome]]: A cross-sectional study<ref name="Mensah, 2016" /> [https://onlinelibrary.wiley.com/doi/full/10.1111/cei.12749 (Full Text)] | *2016, Extended [[B cell]] phenotype in patients with [[ME/CFS|Myalgic Encephalomyelitis/Chronic Fatigue Syndrome]]: A cross-sectional study<ref name="Mensah, 2016" /> [https://onlinelibrary.wiley.com/doi/full/10.1111/cei.12749 (Full Text)] | ||
* 2018, [[CD24]] Expression and [[B cell|B Cell]] Maturation Shows a Novel Link With [[Metabolic|Energy Metabolism]]: Potential Implications for Patients With Myalgic Encephalomyelitis/Chronic Fatigue Syndrome<ref>{{Cite journal|title=CD24 Expression and B Cell Maturation Shows a Novel Link With Energy Metabolism: Potential Implications for Patients With Myalgic Encephalomyelitis/Chronic Fatigue Syndrome|url=https://www.frontiersin.org/articles/10.3389/fimmu.2018.02421/full|journal=Frontiers in Immunology|date=2018|issn=1664-3224|volume=9|doi=10.3389/fimmu.2018.02421|language=English|first = Fane F. K. | last=Mensah | first2 = Christopher W. | last2=Armstrong|first3=Venkat | last3 = Reddy | first4 = Amolak S. | last4 = Bansal | first5 = Saul | last5 = Berkovitz | first6 = Maria J. | last6 = Leandro | first7 = Geraldine | last7 = Cambridge|pages=|via=|author-link=Fane Mensah |author-link2=Christopher Armstrong|author-link7=Geraldine Cambridge|author-link3=Venkat Reddy |author-link4=Amolak Bansal|author-link5=Saul Berkovitz |author-link6=Maria Leandro}}</ref> [https://www.frontiersin.org/articles/10.3389/fimmu.2018.02421/full (Full Text)] | * 2018, [[CD24]] Expression and [[B cell|B Cell]] Maturation Shows a Novel Link With [[Metabolic|Energy Metabolism]]: Potential Implications for Patients With Myalgic Encephalomyelitis/Chronic Fatigue Syndrome<ref>{{Cite journal|title=CD24 Expression and B Cell Maturation Shows a Novel Link With Energy Metabolism: Potential Implications for Patients With Myalgic Encephalomyelitis/Chronic Fatigue Syndrome|url=https://www.frontiersin.org/articles/10.3389/fimmu.2018.02421/full|journal=Frontiers in Immunology|date=2018|issn=1664-3224|volume=9|doi=10.3389/fimmu.2018.02421|language=English|first = Fane F. K. | last = Mensah | first2 = Christopher W. | last2=Armstrong|first3=Venkat | last3 = Reddy | first4 = Amolak S. | last4 = Bansal | first5 = Saul | last5 = Berkovitz | first6 = Maria J. | last6 = Leandro | first7 = Geraldine | last7 = Cambridge|pages=|via=|author-link=Fane Mensah |author-link2=Christopher Armstrong|author-link7=Geraldine Cambridge|author-link3=Venkat Reddy |author-link4=Amolak Bansal|author-link5=Saul Berkovitz |author-link6=Maria Leandro}}</ref> [https://www.frontiersin.org/articles/10.3389/fimmu.2018.02421/full (Full Text)] | ||
== Online presence == | == Online presence == | ||
Revision as of 21:07, October 18, 2022
 | This article is a stub. |
Maria Leandro, MD, PhD, is a Consultant Rheumatologist and a researcher at the Division of Medicine, Centre of Rheumatology Research, University College London, London, United Kingdom. Her research interests are in inflammatory arthritis, rheumatoid arthritis, B cell directed therapies in autoimmune diseases and role of B cells in the pathogenesis of autoimmune diseases.[1]
Notable studies[edit | edit source]
- 2016, Extended B cell phenotype in patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A cross-sectional study[2] (Full Text)
- 2018, CD24 Expression and B Cell Maturation Shows a Novel Link With Energy Metabolism: Potential Implications for Patients With Myalgic Encephalomyelitis/Chronic Fatigue Syndrome[3] (Full Text)
Online presence[edit | edit source]
See also[edit | edit source]
Learn more[edit | edit source]
References[edit | edit source]
- ↑ "Dr Maria Leandro - UCL Hospitals".
- ↑ Mensah, Fane; Bansal, Amolak; Berkovitz, Saul; Sharma, Arti; Reddy, Venkat; Leandro, Maria; Cambridge, Geraldine (2016), "Extended B cell phenotype in patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A cross-sectional study", Clinical and Experimental Immunology, 184 (2): 237-247, doi:10.1111/cei.12749
- ↑ Mensah, Fane F. K.; Armstrong, Christopher W.; Reddy, Venkat; Bansal, Amolak S.; Berkovitz, Saul; Leandro, Maria J.; Cambridge, Geraldine (2018). "CD24 Expression and B Cell Maturation Shows a Novel Link With Energy Metabolism: Potential Implications for Patients With Myalgic Encephalomyelitis/Chronic Fatigue Syndrome". Frontiers in Immunology. 9. doi:10.3389/fimmu.2018.02421. ISSN 1664-3224.
